Polymer micelles for drug delivery

Targeted Delivery of Small and Macromolecular Drugs

Volumn , Issue , 2010, Pages 513-554

  Kim, Sungwon ^a,b   Park, Kinam ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872814433     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420087734     Document Type: Chapter

References (208)

1. Lombardino JG, Lowe JA, 3rd, The role of the medicinal chemist in drug discovery-Then and now. Nat Rev Drug Discov 2004; 3: 853-862.
2. Kramer JA, Sagartz JE, Morris DL, The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nat Rev Drug Discov 2007; 6: 636-649.
3. Lipinski CA, Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000; 44: 235-249.
4. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65: 271-284.
5. Maeda H, Sawa T, Konno T, Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001; 74: 47-61.
6. Iyer AK, Greish K, Seki T, Okazaki S, Fang J, Takeshita K, Maeda H, Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation. J Drug Target 2007; 15: 496-506.
7. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L, Colloidal gold:A novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004; 11: 169-183.
8. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE, Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 2008; 5: 487-495.
9. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK, Bang YJ, Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 2004; 10: 3708-3716.
10. Kim DW, Kim SY, Kim HK, Kim SW, Shin SW, Kim JS, Park K, Lee MY, Heo DS, Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol 2007; 18: 2009-2014.
11. Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim SB, Rha SY, Lee MY, Ro J, Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat 2008; 108: 241-250.
12. Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, Shirao K et al., Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 2004; 91: 1775-1781.
13. Negishi T, Koizumi F, Uchino H, Kuroda J, Kawaguchi T, Naito S, Matsumura Y, NK105, a paclitaxelincorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. Br J Cancer 2006; 95: 601-606.
14. Danson S, Ferry D, Alakhov V, Margison J, Kerr D, Jowle D, Brampton M, Halbert G, Ranson M, Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer 2004; 90: 2085-2091.
15. Hamaguchi T, Kato K, Yasui H, Morizane C, Ikeda M, Ueno H, Muro K et al., A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br J Cancer 2007; 97: 170-176.
16. Merisko-Liversidge EM, Liversidge GG, Drug nanoparticles: Formulating poorly water-soluble compounds. Toxicol Pathol 2008; 36: 43-48.
17. Serajuddin AT, Salt formation to improve drug solubility. Adv Drug Deliv Rev 2007; 59: 603-616.
18. Attwood D, Thermodynamic properties of amphiphilic drugs in aqueous solution. J Chem Soc Faraday Trans I 1989; 85: 3011-3017.
19. Kesisoglou F, Panmai S, Wu Y, Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007; 59: 631-644.
20. Rabinow BE, Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004; 3: 785-796.
21. Keck CM, Muller RH, Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm 2006; 62: 3-16.
22. Strickley RG, Solubilizing excipients in oral and injectable formulations. Pharm Res 2004; 21: 201-230.
23. Buggins TR, Dickinson PA, Taylor G, The effects of pharmaceutical excipients on drug disposition. Adv Drug Deliv Rev 2007; 59: 1482-1503.
24. Brewster ME, Loftsson T, Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007; 59: 645-666.
25. Loftsson T, Duchene D, Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007; 329: 1-11.
26. Osterberg RE, See NA, Toxicity of excipients-a Food and Drug Administration perspective. Int J Toxicol 2003; 22: 377-380.
27. Dye D, Watkins J, Suspected anaphylactic reaction to Cremophor EL. Br Med J 1980; 280: 1353.
28. Strachan EB, Case report-suspected anaphylactic reaction to Cremophor El. SAAD Dig 1981; 4: 209.
29. Barrow PC, Olivier P, Marzin D, The reproductive and developmental toxicity profile of beta-cyclodextrin in rodents. Reprod Toxicol 1995; 9: 389-398.
30. Lina BA, Bar A, Subchronic (13-week) oral toxicity study of alpha-cyclodextrin in dogs. Regul Toxicol Pharmacol 2004; 39(Suppl 1): S27-S33.
31. Ulloth JE, Almaguel FG, Padilla A, Bu L, Liu JW, De Leon M, Characterization of methyl-beta-cyclodextrin toxicity in NGF-differentiated PC12 cell death. Neurotoxicology 2007; 28: 613-621.
32. Serajuddin AT, Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999; 88: 1058-1066.
33. Chawla G, Bansal AK, Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives. Acta Pharm 2008; 58: 257-274.
34. Chiou WL, Riegelman S, Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J Pharm Sci 1969; 58: 1505-1510.
35. Van Balen GP, Martinet GM, Caron G, Bouchard G, Reist M, Carrupt PA, Fruttero R, Gasco A, Testa B, Liposome/water lipophilicity: Methods, information content, and pharmaceutical applications. Med Res Rev 2004; 24: 299-324.
36. Bangham AD, Horne RW, Negative staining of phospholipids and their structural modification by surface- active agents as observed in the electron microscope. J Mol Biol 1964; 8: 660-668.
37. Torchilin VP, Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4: 145-160.
38. Gabizon AA, Shmeeda H, Zalipsky S, Pros and cons of the liposome platform in cancer drug targeting. J Liposome Res 2006; 16: 175-183.
39. Liu D, Liu F, Song YK, Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Biochim Biophys Acta 1995; 1235: 140-146.
40. Yan X, Scherphof GL, Kamps JA, Liposome opsonization. J Liposome Res 2005; 15: 109-139.
41. Papisov MI, Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions. Adv Drug Deliv Rev 1998; 32: 119-138.
42. Chiu GN, Bally MB, Mayer LD, Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). Biochim Biophys Acta 2001; 1510: 56-69.
43. Torchilin V, Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm 2009; 71: 431-444.
44. Amsberry KL, Borchardt RT, Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug. Pharm Res 1991; 8: 323-330.
45. Cook CS, Karabatsos PJ, Schoenhard GL, Karim A, Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334. Pharm Res 1995; 12: 1158-1164.
46. Riley CM, Mummert MA, Zhou J, Schowen RL, Vander Velde DG, Morton MD, Slavik M, Hydrolysis of the prodrug, 2′,3′,5′-triacetyl-6-azauridine. Pharm Res 1995; 12: 1361-1370.
47. Springer CJ, Niculescu-Duvaz II, Antibody-directed enzyme prodrug therapy (ADEPT): A review. Adv Drug Deliv Rev 1997; 26: 151-172.
48. Chen L, Waxman DJ, Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer. Curr Pharm Des 2002; 8: 1405-1416.
49. Ringsdorf H, Structure and properties of pharmacologically active polymers. J Polym Sci Polym Symp 1975; 51: 135-153.
50. Li C, Wallace S, Polymer-drug conjugates: Recent development in clinical oncology. Adv Drug Deliv Rev 2008; 60: 886-898.
51. Kratz F, Muller IA, Ryppa C, Warnecke A, Prodrug strategies in anticancer chemotherapy. Chem Med Chem 2008; 3: 20-53.
52. Hildebrand JH, A critique of the theory of solubility of non-electrolytes. Chem Rev 1949; 44: 37-45.
53. Zeng W, Du Y, Xue Y, Frish HL, In Physical Properties of Polymer Handbook. E. M. James (Ed.) (Springer-Verlag New York, LLC, New York, 2006).
54. Flory PJ, Principle of Polymer Chemistry (Cornell University Press, Ithaca, NY, 1953).
55. Liu R, Forrest ML, Kwon GS, In Water-Insoluble Drug Formulation. R. Liu (Ed.) (CRS Press, Taylor & Francis Group, New York, 2008).
56. Adamska K, Voelkel A, Inverse gas chromatographic determination of solubility parameters of excipients. Int J Pharm 2005; 304: 11-17.
57. Liu J, Xiao Y, Allen C, Polymer-drug compatibility: A guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci 2004; 93: 132-143.
58. Letchford K, Liggins R, Burt H, Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)- block-polycaprolactone diblock copolymer micelles: Theoretical and experimental data and correlations. J Pharm Sci 2008; 97: 1179-1190.
59. Burt HM, Zhang XC, Toleikis P, Embree L, Hunter WL, Development of copolymers of poly(d, l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf B Biointerfaces 1999; 16: 161-171.
60. Vippagunta SR, Brittain HG, Grant DJ, Crystalline solids. Adv Drug Deliv Rev 2001; 48: 3-26.
61. Coffman RE, Kildsig DO, Hydrotropic solubilization-Mechanistic studies. Pharm Res 1996; 13: 1460-1463.
62. Matero A, In Handbook of Applied Surface and Colloid Chemistry. K. Holmberg (Ed.) (John Wiley & Sons, New York, 2001).
63. Ooya T, Lee S, Huh KM, Park K, In Nanocarrier Technologies: Frontiers of Nanotherapy. M. R. Mozafari (Ed.) (Springer, Amsterdam, the Netherlands, 2006).
64. Bauduin P, Renoncourt A, Kopf A, Touraud D, Kunz W, Unified concept of solubilization in water by hydrotropes and cosolvents. Langmuir 2005; 21: 6769-6775.
65. Balasubramanian D, Srinivas V, Gaikar VG, Sharma MM, Aggregation behavior of hydrotropic compounds in aqueous solution. J Phys Chem B 1989; 93: 3865-3870.
66. Neumann MG, Schmitt CC, Prieto KR, Goi BE, The photophysical determination of the minimum hydrotrope concentration of aromatic hydrotropes. J Colloid Interface Sci 2007; 315: 810-813.
67. Sanghvi R, Evans D, Yalkowsky SH, Stacking complexation by nicotinamide: A useful way of enhancing drug solubility. Int J Pharm 2007; 336: 35-41.
68. Coffman RE, Kildsig DO, Self-association of nicotinamide in aqueous solution: Light-scattering and vapor pressure osmometry studies. J Pharm Sci 1996; 85: 848-853.
69. Simamora P, Alvarez JM, Yalkowsky SH, Solubilization of rapamycin. Int J Pharm 2001; 213: 25-29.
70. Evstigneev MP, Evstigneev VP, Santiago AA, Davies DB, Effect of a mixture of caffeine and nicotinamide on the solubility of vitamin (B2) in aqueous solution. Eur J Pharm Sci 2006; 28: 59-66.
71. Landaur J, McConnell H, A study of molecular complexes formed by aniline and aromatic nitrohydrocarbons. J Am Chem Soc 1952; 74: 1221-1224.
72. Mulliken RS, Structures of complexes formed by halogen molecules with aromatic and oxygenated solvent. J Am Chem Soc 1950; 72: 600-608.
73. Lawrey DMG, McConnell H, A spectroscopic study of the benzene-s-Trinitrobenzene molecular complex. J Am Chem Soc 1952; 74: 6175-6177.
74. Hunter CA, Lawson KR, Perkins J, Urch CJ, Aromatic interactions. J Chem Soc Perkin Trans 2001; 2: 651-669.
75. Charman WN, Lai CSC, Craik DJ, Finnin BC, Reed BL, Self-association of nicotinamide in aqueous solution: N.M.R. studies of nicotinamide and the mono- and di-methyl-substituted amide analogues. Aust J Chem 1993; 46: 377-385.
76. Lee SC, Acharya G, Lee J, Park K, Hydrotropic polymers: Synthesis and characterization of polymers containing picolylnicotinamide moieties. Macromolecules 2003; 36: 2248-2255.
77. Rowinsky EK, Donehower RC, Paclitaxel (taxol). N Engl J Med 1995; 332: 1004-1014.
78. Lee J, Lee SC, Acharya G, Chang CJ, Park K, Hydrotropic solubilization of paclitaxel: Analysis of chemical structures for hydrotropic property. Pharm Res 2003; 20: 1022-1030.
79. Rasool AA, Hussain AA, Dittert LW, Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds. J Pharm Sci 1991; 80: 387-393.
80. Agrawal S, Pancholi SS, Jain NK, Agrawal GP, Hydrotropic solubilization of nimesulide for parenteral administration. Int J Pharm 2004; 274: 149-155.
81. Nicoli S, Zani F, Bilzi S, Bettini R, Santi P, Association of nicotinamide with parabens: Effect on solubility, partition and transdermal permeation. Eur J Pharm Biopharm 2008; 69: 613-621.
82. Mansur CR, Pires RV, Gonzalez G, Lucas EF, Influence of the hydrotrope structure on the physical chemical properties of polyoxide aqueous solutions. Langmuir 2005; 21: 2696-2703.
83. Huh KM, Lee SC, Cho YW, Lee J, Jeong JH, Park K, Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release 2005; 101: 59-68.
84. Lee SC, Huh KM, Lee J, Cho YW, Galinsky RE, Park K, Hydrotropic polymeric micelles for enhanced paclitaxel solubility: In vitro and in vivo characterization. Biomacromolecules 2007; 8: 202-208.
85. Kim S, Kim JY, Huh KM, Acharya G, Park K, Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel. J Control Release 2008; 132: 222-229.
86. Huh KM, Min HS, Lee SC, Lee HJ, Kim S, Park K, A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. J Control Release 2008; 126: 122-129.
87. Huang JC, Lin KT, Deanin RD, Three-dimensional solubility parameters of poly(ε~caprolactone). J Appl Polym Sci 2006; 100: 2002-2009.
88. Nair R, Nyamweya N, Gonen S, Martinez-Miranda LJ, Hoag SW, Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): A thermodynamic and spectroscopic investigation. Int J Pharm 2001; 225: 83-96.
89. Mokrushina L, Buggert M, Smirnova I, Arlt W, Schomcker R, COSMO-RS and UNIFAC in prediction of micelle/water partition coefficients. Ind Eng Chem Res 2007; 46: 6501-6509.
90. Hansch C, Quinlan JE, Lawrence GL, The linear free-energy relationship between partition coefficients and the aqueous solubility of organic liquids. J Org Chem 1968; 33: 347-350.
91. Yalkowsky SH, Valvani SC, Solubility and partitioning. I: Solubility of nonelectrolytes in water. J Pharm Sci 1980; 69: 912-922.
92. Yalkowsky SH, He Y, Handbook of Aqueous Solubility Data (CRC Press, New York, 2003).
93. Quina FH, Alonso EO, Farah JPS, Incorporation of nonionic solutes into aqueous micelles: A linear solvation free energy relationship analysis. J Phys Chem 1995; 99: 11708-11714.
94. Abraham MH, Chadha HS, Dixon JP, Rafols C, Treiner C, Hydrogen bonding. Part 41. Factors that influence the distribution of solutes between water and hexadecylpyridinium chloride micelles. J Chem Soc Perkin Trans 1997; 2: 19-24.
95. Rodrigues MA, Alonso EO, Yihwa C, Farah JPS, Quina FH, A linear solvent free energy relationship analysis of solubilization in mixed cationic-nonionic micelles. Langmuir 1999; 15: 6770-6774.
96. Kamlet MJ, Taft RW, Solvatochromic comparison method. 1. Beta-scale of solvent hydrogen-bond acceptor (Hba) basicities. J Am Chem Soc 1976; 98: 377-383.
97. Taft RW, Kamlet MJ, Solvatochromic comparison method. 2. Alpha-scale of solvent hydrogen-bond donor (Hbd) acidities. J Am Chem Soc 1976; 98: 2886-2894.
98. Yokoyama T, Taft RW, Kamlet MJ, Solvatochromic comparison method. 3. Hydrogen-bonding by some 2-nitroaniline derivatives. J Am Chem Soc 1976; 98: 3233-3237.
99. Kamlet MJ, Abboud JL, Taft RW, Solvatochromic comparison method. 6. Pi-star scale of solvent polarities. J Am Chem Soc 1977; 99: 6027-6038.
100. Kim IW, Jang MD, Ryu YK, Cho EH, Lee YK, Park JH, Dipolarity, hydrogen-bond basicity and hydrogen- bond acidity of aqueous poly(ethylene glycol) solutions. Anal Sci 2002; 18: 1357-1360.
101. Nyrkova IA, Semenov AN, Multimerization: Closed or open association model? Eur Phys J E 2005; 17: 327-337.
102. Croy SR, Kwon GS, Polymeric micelles for drug delivery. Curr Pharm Des 2006; 12: 4669-4684.
103. Liu R, Dannenfelser RM, Li S, In Water-Insoluble Drug Formulation. R. Liu (Ed.) (CRC Press, Taylor & Francis Group, New York, 2008).
104. Attwood D, Booth C, Yeates SG, Chaibundit C, Ricardo NM, Block copolymers for drug solubilisation:Relative hydrophobicities of polyether and polyester micelle-core-forming blocks. Int J Pharm 2007; 345: 35-41.
105. Yamamoto Y, Yasugi K, Harada A, Nagasaki Y, Kataoka K, Temperature-related change in the properties relevant to drug delivery of poly(ethylene glycol)-poly(d, l-lactide) block copolymer micelles in aqueous milieu. J Control Release 2002; 82: 359-371.
106. Marques CM, Bunchy micelles. Langmuir 1997; 13: 1430-1433.
107. Allen C, Maysinger D, Eisenberg A, Nano-engineering block copolymer aggregates for drug delivery. Adv Drug Deliv Rev 1999; 16: 3-27.
108. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC, Block copolymer micelles:Preparation, characterization and application in drug delivery. J Control Release 2005; 109: 169-188.
109. Kissel T, Li Y, Unger F, ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Adv Drug Deliv Rev 2002; 54: 99-134.
110. Lan P, Jia L, Thermal properties of copoly(l-lactic acid/glycolic acid) by direct melt polycondensation. J Macromol Sci Pure Appl Chem 2006; 43: 1887-1894.
111. Letchford K, Burt H, A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: Micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 2007; 65: 259-269.
112. Pasquali RC, Taurozzi MP, Bregni C, Some considerations about the hydrophilic-lipophilic balance system. Int J Pharm 2008; 356: 44-51.
113. Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE, Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J Control Release 2006; 116: 150-158.
114. Discher DE, Ahmed F, Polymersomes. Annu Rev Biomed Eng 2006; 8: 323-341.
115. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE, Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2007; 2: 249-255.
116. Aniansson EAG, Wall SN, On the kinetics of step-wise micelle association. J Phys Chem 1974; 78: 1024-1030.
117. Halperin A, Alexander S, Polymer micelles: The relaxation kinetics. Macromolecules 1989; 22: 2403-2412.
118. Prochazka K, Bednar B, Mukhtar E, Svoboda P, Trnena J, Almgren M, Nonradiative energy transfer in block copolymer micelles. J Phys Chem 1991; 95: 4563-4568.
119. Wang Y, Kausch CM, Chun M, Quirk RP, Mattice WL, Exchange of chains between micelles labeled polystyrene- block-poly(oxyethylene) as monitored by nonradiative single energy transfer. Macromolecules 1995; 28: 904-911.
120. Haliloglu T, Bahar I, Erman B, Mattice WL, Mechanisms of the exchange of diblock copolymers between dynamic equilibrium. Macromolecules 1996; 29: 4764-4771.
121. Berney C, Danuser G, FRET or no FRET: A quantitative comparison. Biophys J 2003; 84: 3992-4010.
122. Nyrkova IA, Semenov AN, On the theory of micellization kinetics. Macromol Theory Simul 2005; 14: 569-585.
123. Senichev VY, Tereshatov VV, In Handbook of Plasticizers. G. Wypych (Ed.), (William Andrew Publishing, Norwich, NY, 2004), pp. 218-227.
124. Blasi P, Schoubben A, Giovagnoli S, Perioli L, Ricci M, Rossi C, Ketoprofen poly(lactide-co-glycolide) physical interaction. AAPS Pharm Sci Tech 2007; 8: Article 37.
125. Yang X, Zhu B, Dong T, Pan P, Shuai X, Inoue Y, Interactions between an anticancer drug and polymeric micelles based on biodegradable polyesters. Macromol Biosci 2008; 8: 1116-1125.
126. Liu SQ, Tong YW, Yang YY, Thermally sensitive micelles self-assembled from poly(N-isopropylacrylamide-co-N, N-dimethylacrylamide)-b-poly(d, l-lactide-co-glycolide) for controlled delivery of paclitaxel. Mol Biosyst 2005; 1: 158-165.
127. Chen H, Kim S, He W, Wang H, Low PS, Park K, Cheng JX, Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Forster resonance energy transfer imaging. Langmuir 2008; 24: 5213-5217.
128. Lu RC, Cao AN, Lai LH, Zhu BY, Zhao GX, Xiao JX, Interaction between bovine serum albumin and equimolarly mixed cationic-anionic surfactants decyltriethylammonium bromide-sodium decyl sulfonate. Colloids Surf B Biointerfaces 2005; 41: 139-143.
129. Pi Y, Shang Y, Peng C, Liu H, Hu Y, Jiang J, Interactions between bovine serum albumin and gemini surfactant alkanediyl-alpha, omega-bis(dimethyldodecyl-ammonium bromide). Biopolymers 2006; 83: 243-249.
130. Moore PN, Puvvada S, Blackschtein D, Role of the surfactant polar head structure in protein-surfactant complexation: Zein protein solubilization by SDS and by SDS/C12En surfactant solutions. Langmuir 2003; 19: 1009-1016.
131. Asadi A, Saboury AA, Moosavi-Movahedi AA, Divsalar A, Sarbolouki MN, Interaction of bovine serum albumin with some novel PEG-containing diblock copolymers. Int J Biol Macromol 2008; 43: 262-270.
132. Castelletto V, Krysmann M, Kelarakis A, Jauregi P, Complex formation of bovine serum albumin with a poly(ethylene glycol) lipid conjugate. Biomacromolecules 2007; 8: 2244-2249.
133. Kelarakis A, Castelletto V, Krysmann MJ, Havredaki V, Viras K, Hamley IW, Interactions of bovine serum albumin with ethylene oxide/butylene oxide copolymers in aqueous solution. Biomacromolecules 2008; 9: 1366-1371.
134. Ratner BD, Hoffman A, Schoen F, Lemons J, Biomaterials Science: An Introduction to Materials in Medicine, 2nd edn. (Academic Press, New York, 2004).
135. Amiconi G, Bonaventura C, Bonaventura J, Antonini E, Functional properties of normal and sickle cell hemoglobins in polyethylene glycol 6000. Biochim Biophys Acta 1977; 495: 279-286.
136. McPherson A, Jr., Crystallization of proteins from polyethylene glycol. J Biol Chem 1976; 251: 6300-6303.
137. Lee JC, Lee LL, Preferential solvent interactions between proteins and polyethylene glycols. J Biol Chem 1981; 256: 625-631.
138. Rito-Palomares M, Practical application of aqueous two-phase partition to process development for the recovery of biological products. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 807: 3-11.
139. Fredrickson GH, Pincus P, Drainage of compressed polymer layers - dynamics of a squeezed sponge. Langmuir 1991; 7: 786-795.
140. Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kataoka K, Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Target 1999; 7: 171-186.
141. Armstrong JK, Leharne SA, Stuart BH, Snowden MJ, Chowdhry BZ, Phase transition properties of poly(ethylene oxide) in aqueous solutions of sodium chloride. Langmuir 2001; 17: 4482-4485.
142. Rixman MA, Dean D, Ortiz C, Nanoscale intermolecular interactions between human serum albumin and low grafting density surfaces of poly(ethylene oxide). Langmuir 2003; 19: 9357-9372.
143. Xia JL, Dubin PL, Kokufuta E, Dynamic and electrophoretic light-scattering of a water-soluble complex formed between pepsin and poly(ethylene glycol). Macromolecules 1993; 26: 6688-6690.
144. Topchieva IN, Sorokina EM, Efremova NV, Ksenofontov AL, Kurganov BI, Noncovalent adducts of poly(ethylene glycols) with proteins. Bioconjug Chem 2000; 11: 22-29.
145. Furness EL, Ross A, Davis TP, King GC, A hydrophobic interaction site for lysozyme binding to polyethylene glycol and model contact lens polymers. Biomaterials 1998; 19: 1361-1369.
146. Chia D, Barnett EV, Yamagata J, Knutson D, Restivo C, Furst D, Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG). Clin Exp Immunol 1979; 37: 399-407.
147. Herbert KE, Coppock JS, Griffiths AM, Williams A, Robinson MW, Scott DL, Fibronectin and immune complexes in rheumatic diseases. Ann Rheum Dis 1987; 46: 734-740.
148. Robinson MW, Scott DG, Bacon PA, Walton KW, Coppock JS, Scott DL, What proteins are present in polyethylene glycol precipitates from rheumatic sera? Ann Rheum Dis 1989; 48: 496-501.
149. Cocke DL, Wang HJ, Chen JJ, Interaction between poly(ethylene glycol) and human serum albumin. Chem Commun 1997; 2331-2332.
150. Pico G, Bassani G, Farruggia B, Nerli B, Calorimetric investigation of the protein-flexible chain polymer interactions and its relationship with protein partition in aqueous two-phase systems. Int J Biol Macromol 2007; 40: 268-275.
151. Ragi C, Sedaghat-Herati MR, Ouameur AA, Tajmir-Riahi HA, The effects of poly(ethylene glycol) on the solution structure of human serum albumin. Biopolymers 2005; 78: 231-236.
152. Hasek J, Poly(ethylene glycol) interactions with proteins. Zeitschrift Fur Kristallographie 2006; 613-618.
153. Baier RE, Surface behaviour of biomaterials: The theta surface for biocompatibility. J Mater Sci Mater Med 2006; 17: 1057-1062.
154. Li S, Garreau H, Pauvert B, McGrath J, Toniolo A, Vert M, Enzymatic degradation of block copolymers prepared from epsilon-caprolactone and poly(ethylene glycol). Biomacromolecules 2002; 3: 525-530.
155. Herzog K, Muller RJ, Deckwer WD, Mechanism and kinetics of the enzymatic hydrolysis of polyester nanoparticles by lipases. Polym Degrad Stabil 2006; 91: 2486-2498.
156. Chen DR, Bei JZ, Wang SG, Polycaprolactone microparticles and their biodegradation. Polym Degrad Stabil 2000; 67: 455-459.
157. Carstens MG, van Nostrum CF, Verrijk R, de Leede LG, Crommelin DJ, Hennink WE, A mechanistic study on the chemical and enzymatic degradation of PEG-oligo(epsilon-caprolactone) micelles. J Pharm Sci 2008; 97: 506-518.
158. Chen C, Yu CH, Cheng YC, Yu PH, Cheung MK, Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybutyrate) and poly(ethylene glycol) as drug carriers. Biomaterials 2006; 27: 4804-4814.
159. Mayor S, Pagano RE, Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 2007; 8: 603-612.
160. Sahay G, Batrakova EV, Kabanov AV, Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport. Bioconjug Chem 2008; 19: 2023-2029.
161. Edeling MA, Smith C, Owen D, Life of a clathrin coat: Insights from clathrin and AP structures. Nat Rev Mol Cell Biol 2006; 7: 32-44.
162. Rappoport JZ, Focusing on clathrin-mediated endocytosis. Biochem J 2008; 412: 415-423.
163. Carver LA, Schnitzer JE, Caveolae: Mining little caves for new cancer targets. Nat Rev Cancer 2003; 3: 571-581.
164. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM, The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 2008; 105: 11613-11618.
165. Chen H, Kim S, Li L, Wang S, Park K, Cheng JX, Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging. Proc Natl Acad Sci USA 2008; 105: 6596-6601.
166. Miller DW, Batrakova EV, Waltner TO, Alakhov V, Kabanov AV, Interactions of pluronic block copolymers with brain microvessel endothelial cells: Evidence of two potential pathways for drug absorption. Bioconjug Chem 1997; 8: 649-657.
167. Rapoport N, Marin A, Luo Y, Prestwich GD, Muniruzzaman MD, Intracellular uptake and trafficking of pluronic micelles in drug-sensitive and MDR cells: Effect on the intracellular drug localization. J Pharm Sci 2002; 91: 157-170.
168. Batrakova EV, Li S, Alakhov VY, Miller DW, Kabanov AV, Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther 2003; 304: 845-854.
169. Zastre JA, Jackson JK, Wong W, Burt HM, P-glycoprotein efflux inhibition by amphiphilic diblock copolymers:Relationship between copolymer concentration and substrate hydrophobicity. Mol Pharm 2008; 5: 643-653.
170. Allen C, Yu Y, Eisenberg A, Maysinger D, Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles. Biochim Biophys Acta 1999; 1421: 32-38.
171. Luo L, Tam J, Maysinger D, Eisenberg A, Cellular internalization of poly(ethylene oxide)-b-poly(epsiloncaprolactone) diblock copolymer micelles. Bioconjug Chem 2002; 13: 1259-1265.
172. Savic R, Luo L, Eisenberg A, Maysinger D, Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003; 300: 615-618.
173. Moghimi SM, Hunter AC, Murray JC, Szewczyk A, Cellular distribution of nonionic micelles. Science 2004; 303: 626-628.
174. Maysinger D, Berezovska O, Savic R, Soo PL, Eisenberg A, Block copolymers modify the internalization of micelle-incorporated probes into neural cells. Biochim Biophys Acta 2001; 1539: 205-217.
175. Mahmud A, Lavasanifar A, The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells. Colloids Surf B Biointerfaces 2005; 45: 82-89.
176. Lee RC, River LP, Pan FS, Ji L, Wollmann RL, Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci USA 1992; 89: 4524-4528.
177. Collins JM, Despa F, Lee RC, Structural and functional recovery of electropermeabilized skeletal muscle in-vivo after treatment with surfactant poloxamer 188. Biochim Biophys Acta 2007; 1768: 1238-1246.
178. Maskarinec SA, Wu G, Lee KY, Membrane sealing by polymers. Ann NY Acad Sci 2005; 1066: 310-320.
179. Lentz BR, PEG as a tool to gain insight into membrane fusion. Eur Biophys J 2007; 36: 315-326.
180. Blow AM, Botham GM, Fisher D, Goodall AH, Tilcock CP, Lucy JA, Water and calcium ions in cell fusion induced by poly(ethylene glycol). FEBS Lett 1978; 94: 305-310.
181. Wu JR, Lentz BR, Mechanism of poly(ethylene glycol)-induced lipid transfer between phosphatidylcholine large unilamellar vesicles: A fluorescent probe study. Biochemistry 1991; 30: 6780-6787.
182. Burgess SW, Massenburg D, Yates J, Lentz BR, Poly(ethylene glycol)-induced lipid mixing but not fusion between synthetic phosphatidylcholine large unilamellar vesicles. Biochemistry 1991; 30: 4193-4200.
183. Talbot WA, Zheng LX, Lentz BR, Acyl chain unsaturation and vesicle curvature alter outer leaflet packing and promote poly(ethylene glycol)-mediated membrane fusion. Biochemistry 1997; 36: 5827-5836.
184. Shi R, Borgens RB, Acute repair of crushed guinea pig spinal cord by polyethylene glycol. J Neurophysiol 1999; 81: 2406-2414.
185. Liu-Snyder P, Logan MP, Shi R, Smith DT, Borgens RB, Neuroprotection from secondary injury by polyethylene glycol requires its internalization. J Exp Biol 2007; 210: 1455-1462.
186. Batrakova EV, Li S, Li Y, Alakhov VY, Elmquist WF, Kabanov AV, Distribution kinetics of a micelleforming block copolymer Pluronic P85. J Control Release 2004; 100: 389-397.
187. Rudin M, Weissleder R, Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2003; 2: 123-131.
188. Park YJ, Lee JY, Chang YS, Jeong JM, Chung JK, Lee MC, Park KB, Lee SJ, Radioisotope carrying polyethylene oxide-polycaprolactone copolymer micelles for targetable bone imaging. Biomaterials 2002; 23: 873-879.
189. Liu J, Zeng F, Allen C, In vivo fate of unimers and micelles of a poly(ethylene glycol)-blockpoly(caprolactone) copolymer in mice following intravenous administration. Eur J Pharm Biopharm 2007; 65: 309-319.
190. Savic R, Azzam T, Eisenberg A, Maysinger D, Assessment of the integrity of poly(caprolactone)-bpoly(ethylene oxide) micelles under biological conditions: A fluorogenic-based approach. Langmuir 2006; 22: 3570-3578.
191. Novakova K, Laznicek M, Rypacek F, Machova L, Pharmacokinetics and distribution of 125I-PLA-b-PEO block copolymers in rats. Pharm Dev Technol 2003; 8: 153-161.
192. Novakova K, Laznicek M, 125I-labeled PLA/PEO block copolymer: Biodistribution studies in rats. J Bioact Compat Polym 2002; 17: 285-296.
193. Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K, Long-circulating poly(ethylene glycol)- poly(D, L-lactide) block copolymer micelles with modulated surface charge. J Control Release 2001; 77: 27-38.
194. Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 1991; 51: 3229-3236.
195. Sun X, Rossin R, Turner JL, Becker ML, Joralemon MJ, Welch MJ, Wooley KL, An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. Biomacromolecules 2005; 6: 2541-2554.
196. Sun G, Hagooly A, Xu J, Nystrom AM, Li Z, Rossin R, Moore DA, Wooley KL, Welch MJ, Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles. Biomacromolecules 2008; 9: 1997-2006.
197. Sezgin Z, Yuksel N, Baykara T, Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm 2006; 64: 261-268.
198. Torchilin VP, Micellar nanocarriers: Pharmaceutical perspectives. Pharm Res 2007; 24: 1-16.
199. Wooley KL, Shell crosslinked polymer assemblies: Nanoscale constructs inspired from biological systems. J Polym Sci A: Polym Chem 2000; 38: 1397-1407.
200. O’Reilly RK, Hawker CJ, Wooley KL, Cross-linked block copolymer micelles: Functional nanostructures of great potential and versatility. Chem Soc Rev 2006; 35: 1068-1083.
201. Shuai X, Merdan T, Schaper AK, Xi F, Kissel T, Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug Chem 2004; 15: 441-448.
202. Li Y, Lokitz BS, Armes SP, McCormick CL, Synthesis of reversible shell cross-linked micelles for controlled release of bioactive agents. Macromolecules 2006; 39: 2726-2728.
203. Kohn J, New approaches to biomaterials design. Nat Mater 2004; 3: 745-747.
204. Kohn J, Welsh WJ, Knight D, A new approach to the rationale discovery of polymeric biomaterials. Biomaterials 2007; 28: 4171-4177.
205. Matyjaszewski K, Xia J, Atom transfer radical polymerization. Chem Rev 2001; 101: 2921-2990.
206. Stenzel MH, RAFT polymerization: An avenue to functional polymeric micelles for drug delivery. Chem Commun 2008; 14: 3486-3503.
207. Hawker CJ, Bosman AW, Harth E, New polymer synthesis by nitroxide mediated living radical polymerizations. Chem Rev 2001; 101: 3661-3688.
208. Kwon IK, Kim SW, Chaterji S, Vedantham K, Park K, in Smart Materials, M. Schwartz (Ed.) (Taylor & Francis Group, LLC, Boca Raton, FL, 2009), pp. 13-1-13-10.